Companies: 10,795·Total market cap: $144.5T
MetaVia Inc.

MetaVia Inc.

MTVANASDAQHealthcare● Active
$1.72
$-0.51(-22.75%)
Market Cap$3775483
P/E Ratio—
52W High$19.03
52W Low$0.966
Overview

MetaVia Inc. (MTVA) SEC Filings & 10-K Annual Reports

SEC EDGAR regulatory submissions (10-K, 10-Q, 8-K), latest forms, and full filing history — quick links to financials and earnings below.

SEC EDGAR · data.sec.gov · CIK 0001638287 · MTVA · NASDAQ · as of Jun 9, 2026

Filing snapshot

616
Total Filings
4
Latest Form
2026-06-08
Most Recent
2016
Filing Since
FinancialsEarningsView All on EDGAR

Source: SEC EDGAR (data.sec.gov) · CIK 0001638287 · Updated hourly · Not investment advice

Latest Annual Report

10-K · Annual ReportFY
Filed Date
2026-03-26
Fiscal Year End
Mar 26, 2026
Accession No.
0001104659-26-034911
Primary Document
mtva-20251231x10k.htm
View on SEC EDGARDownload PDFFiling Index
Source: data.sec.gov · CIK 0001638287 · Accession 0001104659-26-034911

Latest Key Filings

10-QQuarterly Report
10-Q
2026-05-14
View 10-Q on SEC
8-KCurrent Report
FORM 8-K
2026-06-08Material Event
View 8-K on SEC
Form 4Insider Activity
Ownership Change Disclosures

Executive & director trade disclosures. Full buy/sell sentiment analysis on the dedicated tab.

View Insider Trades Tab

SEC Filing History

Hide Form 4 / 144
S-8Employee Stock Plan Registration
FORM S-8
2026-06-08
View
8-KCurrent Report
FORM 8-K
2026-06-08
View
8-KCurrent Report
8-K
2026-06-08
View
8-KCurrent Report
8-K
2026-05-27
View
8-KCurrent Report
8-K
2026-05-18
View
SCHEDULE 13GSCHEDULE 13G
SCHEDULE 13G
2026-05-15
View
10-QQuarterly Report
10-Q
2026-05-14
View
8-KCurrent Report
8-K
2026-05-14
View
8-KCurrent Report
8-K
2026-05-11
View
ARSARS
ARS
2026-04-27
View
DEF 14AProxy Statement
DEF 14A
2026-04-27
View
PRE 14APRE 14A
PRE 14A
2026-04-15
View
8-KCurrent Report
8-K
2026-04-10
View
424B3424B3
424B3
2026-04-07
View
EFFECTEFFECT
EFFECT
2026-04-06
View
Showing 1–15 of 498 filingsForm 4 / 144 hidden· 616 total in EDGAR

About SEC Filings & 10-K Annual Reports

Data source: SEC EDGAR (data.sec.gov)  |  Updated: Hourly  |  CIK: 0001638287  |  Exchange: NASDAQ · Healthcare

MetaVia Inc. (NASDAQ: MTVA) has submitted 616 documents to the U.S. Securities and Exchange Commission (SEC) since its IPO in 2016. As a Healthcare sector company with CIK 0001638287, all filings are publicly accessible via the EDGAR database at no cost.

The annual 10-K report is MetaVia Inc.'s most comprehensive regulatory disclosure. The most recent MetaVia Inc. 10-K was filed on 2026-03-26 for fiscal year ending 2026. Historical MTVA 10-K annual reports are available from 2015 through 2026.

Investors researching MetaVia Inc. SEC filings can access 10-K annual reports, quarterly 10-Q reports, material event 8-K filings, and proxy statements directly from the links above. All documents are sourced from the official SEC EDGAR system.

Source: SEC EDGAR · data.sec.gov · SEC Form 10-K · SEC Form 10-Q · SEC Form 8-K2026-06-09
Related Companies SEC Filings — Healthcare
LSTA SEC Filings →KLTO SEC Filings →XCUR SEC Filings →PASG SEC Filings →ENLV SEC Filings →NCNA SEC Filings →SONN SEC Filings →CLGN SEC Filings →
→ MTVA Financials→ MTVA Earnings→ MTVA Insider Trades

Frequently Asked Questions

MTVA SEC Filings · 8 questions

MetaVia Inc. (MTVA) SEC filings are publicly available on this page and on the official SEC EDGAR database at sec.gov. You can browse all 616 filings and access original documents at no cost. MetaVia Inc.'s CIK is 0001638287.

MTVA SEC filingsMetaVia Inc. SEC documentsfind MTVA 10-K